How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

66

HKG:6600
Get a brief AI stock analysisSaves ~ 15 minutes of your time

66

SciClone Pharmaceuticals (Holdings) LtdHKG 6600 Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XHKG - Hong Kong Exchange

FAIR VALUE

Is 6600 undervalued compared to its fair value?

The fair value of 6600 stock is hidden HKD. Relative to the market price of 18.72 HKD SciClone Pharmaceuticals (Holdings) Ltd is hidden.

SciClone Pharmaceuticals (Holdings) Ltd. is an investment holding company which manufactures and markets immune and oncology pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently emplo...[More about valuation]

SciClone Pharmaceuticals (Holdings) Fair Value

Available for registered user
UNLOCK
What is fair value?

Market cap:

1.511 $B

Price:

18.72 HKD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

0.764

FINANCIALS

SciClone Pharmaceuticals (Holdings) financial for reporting period

Income Statement

1.6 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.49 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

1.6 B 100%
1.2 B 75%
0.49 B 32%

Balance Sheet

4 B
3.3 B

Financial Position Analysis

Assets

4 B
Current Assets
3.4 B
Total non-current assets
0.55 B

Total current liabilities
0.7 B
Total non-current liabilities
0.037 B

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.82 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

SciClone Pharmaceuticals (Holdings) fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

37 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
67 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
27 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

SciClone Pharmaceuticals Rating

Is 6600 attractive for investment based on fundamental analysis?

6600 stock rating is hidden. SciClone Pharmaceuticals (Holdings) is a hidden by Eyestock methodology.

Get 6600 Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

36

Gross Margin:

75

CFO / Debt ratio:

hidden

Current ratio:

4.29

Debt / Equity ratio:

0.15

ROE:

37

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

6600.HK analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for 6600.HK to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

SciClone Pharmaceuticals (Holdings) Ltd dividends

SciClone Pharmaceuticals (Holdings) Ltd dividend yield is 3.80%

The annual dividend is 0.39 HKD

6600.HK dividend metrics

Payout ratio
32.30%
Dividend yield
3.80%
Annual dividend
0.39
Dividend streak
2 years
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About 6600.HK stock

About the company SciClone Pharmaceuticals (Holdings) Ltd

Market cap $B

1.511

Dividend yield

3.80 %

Shares outstanding

606.646337 B

SciClone Pharmaceuticals (Holdings) Ltd. is an investment holding company which manufactures and markets immune and oncology pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 770 full-time employees. The company went IPO on 2021-03-03. The firm primarily engages in the sales of its proprietary product, Zadaxin, its in-licensed products and promotion products on behalf of its business partners in China.

6600.HK profile

  • Ticker

    6600.HK

  • Country

    China

  • Exchange

    XHKG - Hong Kong Exchange

  • Report currency

    CNY - Chinese yuan

  • IPO date

    03 March 2021

  • Sector

    Healthсare

  • Industry

    Pharmaceuticals

  • Employees

    770

  • City

    Shanghai

  • Address

    22/F, Central Plaza, 381 Middle Huaihai Road

  • Cusip

    G4271B102

6600.HK market tickers

OOTC - OTC

SCCPF

Frequently Asked Questions

What sector does SciClone Pharmaceuticals operate in?

SciClone Pharmaceuticals operates in Healthсare sector

What is market cap of SciClone Pharmaceuticals?

Market cap of SciClone Pharmaceuticals is 1.511 USD as of 24 Jul 2024

What is market price of one 6600 stock?

Market price of one 6600 stock is 18.72 HKD as of 24 Jul 2024

What is SciClone Pharmaceuticals revenue?

According to the recent report SciClone Pharmaceuticals revenue is 1552.283

What is SciClone Pharmaceuticals net income?

According to the recent report SciClone Pharmaceuticals net icnome is 491.719

What is SciClone Pharmaceuticals net income growh rate?

Net income growth rate of SciClone Pharmaceuticals is 67